Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
21. November 2024 07:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
19. November 2024 16:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors